JUN 01, 2020 1:19 PM PDT

Spit in the vial to test your cancer risk

A Stand Up To Cancer program is trying to improve access to genetic testing for those who might be at risk of hereditary cancers. In a trial called MAGENTA (Making GENetic Testing Accessible), almost 4,000 women from all 50 US states participated in a randomized study to evaluate unique strategies of remote pre- and post-test genetic counseling for cancer risk. The results from the trial were presented recently at the American Society of Clinical Oncology's annual meeting.

The women who participated in the trial had a family history of breast or ovarian cancer or had a family member with a known genetic mutation. The participants used a saliva kit in their own homes to conduct genetic testing for 19 genes associated with inherited cancer risk. 

The results from the trial demonstrated that genetic testing can be provided remotely, which the researchers say is unequivocally timely given the current state of the country.

"The MAGENTA trial results are especially relevant now given the fact that the coronavirus pandemic is necessitating the timely and effective delivery of virtual healthcare," said Elizabeth Swisher, MD, co-leader of the Stand Up To Cancer Dream Team and director of the Division of Gynecologic Oncology at UW School of Medicine. "There are many benefits to this new design, so I do see genetic testing for medical purposes headed in this direction, regardless of the pandemic." The researchers’ work was co-funded by Ovarian Cancer Research Alliance and the National Ovarian Cancer Coalition.

Another finding from the trial showed that genetic counseling before and after testing can be skipped without causing increased distress to patients undergoing genetic testing from their home.

Photo: Pixabay

"These trial results are not only tangible but empowering for women with inherited risk for ovarian cancer," said Melissa Aucoin, CEO of the National Ovarian Cancer Coalition. "With the vast majority of women diagnosed in late stages, improving preventative measures can have a significant impact on the future of ovarian cancer..."

Karen Lu, MD, was the principal investigator of the study. A professor and chair of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center, Lu commented on the implications that the MAGENTA trial holds for many at-risk individuals. "The majority of individuals meeting the U.S. Preventative Services Task Force guidelines for genetic testing have not received genetic testing or counseling. The results of this study demonstrate that using online and remote methods for preventative testing and genetic counseling can be an option to help break down barriers and expand the availability of preventative cancer care."

Sources: Stand Up To Cancer, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAR 22, 2021
Immunology
Gene Mutation Keeps Tumors "Cold"
MAR 22, 2021
Gene Mutation Keeps Tumors "Cold"
Immunologists have identified a mechanism through which an oncogene mutation shields pancreatic tumors from immune cells ...
APR 12, 2021
Cancer
Using antibodies to treat melanoma
APR 12, 2021
Using antibodies to treat melanoma
New research presented at the American Association of Cancer Research (AACR) virtual annual meeting this week from the Y ...
MAY 10, 2021
Cancer
Advancements in nanotech pave the way for improved chemotherapy
MAY 10, 2021
Advancements in nanotech pave the way for improved chemotherapy
New research from Massachusetts General Hospital (MGH) reports on a development in improving the effectiveness of c ...
JUN 07, 2021
Cell & Molecular Biology
Overcoming Challenges to Detect Apoptosis in 3D Cell Structures
JUN 07, 2021
Overcoming Challenges to Detect Apoptosis in 3D Cell Structures
Researchers are increasingly relying on cells grown in three-dimensional (3D) structures to help answer their research q ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
JUN 16, 2021
Cancer
New drug attacks pancreatic tumors with mutant KRAS addiction
JUN 16, 2021
New drug attacks pancreatic tumors with mutant KRAS addiction
Pancreatic cancer is notoriously difficult to detect in early stages, which is why it is associated with a low survival ...
Loading Comments...